Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation.

ABSTRACT:

SUBMITTER: Adnan Awad S 

PROVIDER: S-EPMC9021312 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature